Sanofi-aventis expresses concern over the approval of another version of enoxaparin sodium
- Details
- Category: Sanofi

Sandoz leads the way with first generic version of 'gold standard' anti-thrombotic Lovenox®
- Details
- Category: Novartis

Roche posts good half year results
- Details
- Category: Roche

Pfizer to Offer Free Public Access to Mental Health Assessment Tools
- Details
- Category: Pfizer

Bristol-Myers Squibb Second Quarter Featured Robust Clinical Data and Double-Digit EPS Growth
- Details
- Category: Bristol-Myers Squibb

GlaxoSmithKline statement in response to FDA announcement on TIDE trial
- Details
- Category: GlaxoSmithKline

Abbott Reports Strong Second Quarter Results
- Details
- Category: Abbott

More Pharma News ...
- Novartis delivers strong financial performance in second quarter
- Bayer Schering Pharma enters strategic partnership with Hospital in China
- FDA Grants Priority Review Designation to Denosumab
- Mylan to Acquire Bioniche Pharma Global Injectable Pharmaceuticals Business
- Amgen Foundation and Changemakers Launch Global Online Competition to Empower Patients
- GlaxoSmithKline (GSK) responds to Senate Finance Committee letter
- Pfizer Strengthens Manufacturing Capabilities in Asia